<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32090465</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>27</Day></DateCompleted><DateRevised><Year>2021</Year><Month>04</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1469-3178</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>4</Issue><PubDate><Year>2020</Year><Month>Apr</Month><Day>03</Day></PubDate></JournalIssue><Title>EMBO reports</Title><ISOAbbreviation>EMBO Rep</ISOAbbreviation></Journal><ArticleTitle>Proteasome mapping reveals sexual dimorphism in tissue-specific sensitivity to protein aggregations.</ArticleTitle><Pagination><StartPage>e48978</StartPage><MedlinePgn>e48978</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e48978</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.15252/embr.201948978</ELocationID><Abstract><AbstractText>Defects in the proteasome can result in pathological proteinopathies. However, the pathogenic role of sex- and tissue-specific sensitivity to proteotoxic stress remains elusive. Here, we map the proteasome activity across nine tissues, in male and female mice, and demonstrate strong sexual dimorphism in proteasome activity, where females have significantly higher activity in several tissues. Further, we report drastic differences in proteasome activity among tissues, independently of proteasome concentration, which are exacerbated under stress conditions. Sexual dimorphism in proteasome activity is confirmed in a SOD1 ALS mouse model, in which the spinal cord, a tissue with comparatively low proteasome activity, is severely affected. Our results offer mechanistic insight into tissue-specific sensitivities to proteostasis stress and into sex differences in the progression of neurodegenerative proteinopathies.</AbstractText><CopyrightInformation>&#xa9; 2020 The Authors. Published under the terms of the CC BY NC ND 4.0 license.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jenkins</LastName><ForeName>Edmund Charles</ForeName><Initials>EC</Initials><AffiliationInfo><Affiliation>Division of Hematology/Oncology, Department of Medicine, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Nagma</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Division of Hematology/Oncology, Department of Medicine, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gomez</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Hematology/Oncology, Department of Medicine, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casalena</LastName><ForeName>Gabriella</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Dazhi</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kenny</LastName><ForeName>Timothy C</ForeName><Initials>TC</Initials><AffiliationInfo><Affiliation>Division of Hematology/Oncology, Department of Medicine, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guariglia</LastName><ForeName>Sara Rose</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>City University of New York, College of Staten Island, Staten Island, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manfredi</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-3893-1348</Identifier><AffiliationInfo><Affiliation>Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Germain</LastName><ForeName>Doris</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-6597-0196</Identifier><AffiliationInfo><Affiliation>Division of Hematology/Oncology, Department of Medicine, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS062055</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS084486</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 CA078207</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>02</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>EMBO Rep</MedlineTA><NlmUniqueID>100963049</NlmUniqueID><ISSNLinking>1469-221X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D066329">Protein Aggregates</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.25.1</RegistryNumber><NameOfSubstance UI="D046988">Proteasome Endopeptidase Complex</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D046988" MajorTopicYN="N">Proteasome Endopeptidase Complex</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066329" MajorTopicYN="N">Protein Aggregates</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012727" MajorTopicYN="Y">Sex Characteristics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">gender differences</Keyword><Keyword MajorTopicYN="N">proteasome</Keyword><Keyword MajorTopicYN="N">protein aggregates</Keyword><Keyword MajorTopicYN="N">ubiquitin</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>7</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>1</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>1</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32090465</ArticleId><ArticleId IdType="pmc">PMC7132179</ArticleId><ArticleId IdType="doi">10.15252/embr.201948978</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tanaka K, Mizushima T, Saeki Y (2012) The proteasome: molecular machinery and pathophysiological roles. Biol Chem 393: 217&#x2013;234</Citation><ArticleIdList><ArticleId IdType="pubmed">23029643</ArticleId></ArticleIdList></Reference><Reference><Citation>Rousseau A, Bertolotti A (2018) Regulation of proteasome assembly and activity in health and disease. Nat Rev Mol Cell Biol 19: 697&#x2013;712</Citation><ArticleIdList><ArticleId IdType="pubmed">30065390</ArticleId></ArticleIdList></Reference><Reference><Citation>Murata S, Takahama Y, Kasahara M, Tanaka K (2018) The immunoproteasome and thymoproteasome: functions, evolution and human disease. Nat Immunol 19: 923&#x2013;931</Citation><ArticleIdList><ArticleId IdType="pubmed">30104634</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt M, Finley D (2014) Regulation of proteasome activity in health and disease. Biochim Biophys Acta 1843: 13&#x2013;25</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3858528</ArticleId><ArticleId IdType="pubmed">23994620</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes AV (2013) Genetics of proteasome diseases. Scientifica (Cairo) 2013: 637629</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3892944</ArticleId><ArticleId IdType="pubmed">24490108</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleynen I, Vazeille E, Artieda M, Verspaget HW, Szczypiorska M, Bringer MA, Lakatos PL, Seibold F, Parnell K, Weersma RK et&#xa0;al (2014) Genetic and microbial factors modulating the ubiquitin proteasome system in inflammatory bowel disease. Gut 63: 1265&#x2013;1274</Citation><ArticleIdList><ArticleId IdType="pubmed">24092863</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandhi J, Antonelli AC, Afridi A, Vatsia S, Joshi G, Romanov V, Murray IVJ, Khan SA (2019) Protein misfolding and aggregation in neurodegenerative diseases: a review of pathogeneses, novel detection strategies, and potential therapeutics. Rev Neurosci 30: 339&#x2013;358</Citation><ArticleIdList><ArticleId IdType="pubmed">30742586</ArticleId></ArticleIdList></Reference><Reference><Citation>Briston T, Hicks AR (2018) Mitochondrial dysfunction and neurodegenerative proteinopathies: mechanisms and prospects for therapeutic intervention. Biochem Soc Trans 46: 829&#x2013;842</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6103456</ArticleId><ArticleId IdType="pubmed">29986938</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciechanover A (1994) The ubiquitin&#x2010;proteasome proteolytic pathway. Cell 79: 13&#x2013;21</Citation><ArticleIdList><ArticleId IdType="pubmed">7923371</ArticleId></ArticleIdList></Reference><Reference><Citation>Hershko A, Ciechanover A (1998) The ubiquitin system. Annu Rev Biochem 67: 425&#x2013;479</Citation><ArticleIdList><ArticleId IdType="pubmed">9759494</ArticleId></ArticleIdList></Reference><Reference><Citation>Song L, Luo ZQ (2019) Post&#x2010;translational regulation of ubiquitin signaling. J Cell Biol 218: 1776&#x2013;1786</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6548142</ArticleId><ArticleId IdType="pubmed">31000580</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins GA, Goldberg AL (2017) The logic of the 26S proteasome. Cell 169: 792&#x2013;806</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5609836</ArticleId><ArticleId IdType="pubmed">28525752</ArticleId></ArticleIdList></Reference><Reference><Citation>Budenholzer L, Cheng CL, Li Y, Hochstrasser M (2017) Proteasome structure and assembly. J Mol Biol 429: 3500&#x2013;3524</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5675778</ArticleId><ArticleId IdType="pubmed">28583440</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomaru U, Takahashi S, Ishizu A, Miyatake Y, Gohda A, Suzuki S, Ono A, Ohara J, Baba T, Murata S et&#xa0;al (2012) Decreased proteasomal activity causes age&#x2010;related phenotypes and promotes the development of metabolic abnormalities. Am J Pathol 180: 963&#x2013;972</Citation><ArticleIdList><ArticleId IdType="pubmed">22210478</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahlmann B (2016) Mammalian proteasome subtypes: their diversity in structure and function. Arch Biochem Biophys 591: 132&#x2013;140</Citation><ArticleIdList><ArticleId IdType="pubmed">26724758</ArticleId></ArticleIdList></Reference><Reference><Citation>Morozov AV, Karpov VL (2018) Biological consequences of structural and functional proteasome diversity. Heliyon 4: e00894</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6218844</ArticleId><ArticleId IdType="pubmed">30417153</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Zhao Z, Luo Y, Chen G, Li Z (2011) Gel&#x2010;based proteomics analysis of the heterogeneity of 20S proteasomes from four human pancreatic cancer cell lines. Proteomics Clin Appl 5: 484&#x2013;492</Citation><ArticleIdList><ArticleId IdType="pubmed">21751412</ArticleId></ArticleIdList></Reference><Reference><Citation>Baraibar MA, Liu L, Ahmed EK, Friguet B (2012) Protein oxidative damage at the crossroads of cellular senescence, aging, and age&#x2010;related diseases. Oxid Med Cell Longev 2012: 919832</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3483731</ArticleId><ArticleId IdType="pubmed">23125894</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Yen J, Kaiser P, Huang L (2010) Regulation of the 26S proteasome complex during oxidative stress. Sci Signal 3: ra88</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3140957</ArticleId><ArticleId IdType="pubmed">21139140</ArticleId></ArticleIdList></Reference><Reference><Citation>Bajorek M, Finley D, Glickman MH (2003) Proteasome disassembly and downregulation is correlated with viability during stationary phase. Curr Biol 13: 1140&#x2013;1144</Citation><ArticleIdList><ArticleId IdType="pubmed">12842014</ArticleId></ArticleIdList></Reference><Reference><Citation>Labbadia J, Morimoto RI (2014) Proteostasis and longevity: when does aging really begin? F1000Prime Rep 6: 7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3914504</ArticleId><ArticleId IdType="pubmed">24592319</ArticleId></ArticleIdList></Reference><Reference><Citation>Morimoto RI, Cuervo AM (2014) Proteostasis and the aging proteome in health and disease. J Gerontol A Biol Sci Med Sci 69(Suppl 1): S33&#x2013;S38</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4022129</ArticleId><ArticleId IdType="pubmed">24833584</ArticleId></ArticleIdList></Reference><Reference><Citation>Sala AJ, Bott LC, Morimoto RI (2017) Shaping proteostasis at the cellular, tissue, and organismal level. J Cell Biol 216: 1231&#x2013;1241</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5412572</ArticleId><ArticleId IdType="pubmed">28400444</ArticleId></ArticleIdList></Reference><Reference><Citation>Walther DM, Kasturi P, Zheng M, Pinkert S, Vecchi G, Ciryam P, Morimoto RI, Dobson CM, Vendruscolo M, Mann M et&#xa0;al (2015) Widespread proteome remodeling and aggregation in aging C. elegans . Cell 161: 919&#x2013;932</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4643853</ArticleId><ArticleId IdType="pubmed">25957690</ArticleId></ArticleIdList></Reference><Reference><Citation>Heiman&#x2010;Patterson TD, Deitch JS, Blankenhorn EP, Erwin KL, Perreault MJ, Alexander BK, Byers N, Toman I, Alexander GM (2005) Background and gender effects on survival in the TgN(SOD1&#x2010;G93A)1Gur mouse model of ALS. J Neurol Sci 236: 1&#x2013;7</Citation><ArticleIdList><ArticleId IdType="pubmed">16024047</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanhill A, Haynes CM, Zhang Y, Min G, Steele MC, Kalinina J, Martinez E, Pickart CM, Kong XP, Ron D (2006) An arsenite&#x2010;inducible 19S regulatory particle&#x2010;associated protein adapts proteasomes to proteotoxicity. Mol Cell 23: 875&#x2013;885</Citation><ArticleIdList><ArticleId IdType="pubmed">16973439</ArticleId></ArticleIdList></Reference><Reference><Citation>Yun C, Stanhill A, Yang Y, Zhang Y, Haynes CM, Xu CF, Neubert TA, Mor A, Philips MR, Ron D (2008) Proteasomal adaptation to environmental stress links resistance to proteotoxicity with longevity in Caenorhabditis elegans . Proc Natl Acad Sci USA 105: 7094&#x2013;7099</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2383958</ArticleId><ArticleId IdType="pubmed">18467495</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerrero&#x2010;Garcia TA, Gandolfi S, Laubach JP, Hideshima T, Chauhan D, Mitsiades C, Anderson KC, Richardson PG (2018) The power of proteasome inhibition in multiple myeloma. Expert Rev Proteomics 15: 1033&#x2013;1052</Citation><ArticleIdList><ArticleId IdType="pubmed">30427223</ArticleId></ArticleIdList></Reference><Reference><Citation>Bross PF, Kane R, Farrell AT, Abraham S, Benson K, Brower ME, Bradley S, Gobburu JV, Goheer A, Lee SL et&#xa0;al (2004) Approval summary for bortezomib for injection in the treatment of multiple myeloma. Clin Cancer Res 10: 3954&#x2013;3964</Citation><ArticleIdList><ArticleId IdType="pubmed">15217925</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallanat B, Anderson SP, Brown&#x2010;Borg HM, Ren H, Kersten S, Jonnalagadda S, Srinivasan R, Corton JC (2010) Analysis of the heat shock response in mouse liver reveals transcriptional dependence on the nuclear receptor peroxisome proliferator&#x2010;activated receptor alpha (PPARalpha). BMC Genom 11: 16</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2823686</ArticleId><ArticleId IdType="pubmed">20059764</ArticleId></ArticleIdList></Reference><Reference><Citation>Elsasser S, Schmidt M, Finley D (2005) Characterization of the proteasome using native gel electrophoresis. Methods Enzymol 398: 353&#x2013;363</Citation><ArticleIdList><ArticleId IdType="pubmed">16275342</ArticleId></ArticleIdList></Reference><Reference><Citation>Riar AK, Burstein SR, Palomo GM, Arreguin A, Manfredi G, Germain D (2017) Sex specific activation of the ERalpha axis of the mitochondrial UPR (UPRmt) in the G93A&#x2010;SOD1 mouse model of familial ALS. Hum Mol Genet 26: 1318&#x2013;1327</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6075578</ArticleId><ArticleId IdType="pubmed">28186560</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>